NM_000940.3:c.695+267C>T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000940.3(PON3):c.695+267C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.477 in 487,068 control chromosomes in the GnomAD database, including 58,726 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.44   (  15798   hom.,  cov: 32) 
 Exomes 𝑓:  0.49   (  42928   hom.  ) 
Consequence
 PON3
NM_000940.3 intron
NM_000940.3 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.648  
Publications
7 publications found 
Genes affected
 PON3  (HGNC:9206):  (paraoxonase 3) This gene is a member of the paraoxonase family and lies in a cluster on chromosome 7 with the other two family members. The encoded protein is secreted into the bloodstream and associates with high-density lipoprotein (HDL). The protein also rapidly hydrolyzes lactones and can inhibit the oxidation of low-density lipoprotein (LDL), a function that is believed to slow the initiation and progression of atherosclerosis. Alternatively spliced variants which encode different protein isoforms have been described; however, only one has been fully characterized. [provided by RefSeq, Jul 2008] 
PON3 Gene-Disease associations (from GenCC):
- amyotrophic lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87). 
BP6
Variant 7-95363596-G-A is Benign according to our data. Variant chr7-95363596-G-A is described in ClinVar as Benign. ClinVar VariationId is 1239780.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.718  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.442  AC: 66920AN: 151544Hom.:  15791  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
66920
AN: 
151544
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.494  AC: 165578AN: 335410Hom.:  42928  Cov.: 2 AF XY:  0.501  AC XY: 89715AN XY: 179100 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
165578
AN: 
335410
Hom.: 
Cov.: 
2
 AF XY: 
AC XY: 
89715
AN XY: 
179100
show subpopulations 
African (AFR) 
 AF: 
AC: 
3006
AN: 
9856
American (AMR) 
 AF: 
AC: 
8881
AN: 
15104
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
3884
AN: 
10022
East Asian (EAS) 
 AF: 
AC: 
15652
AN: 
20438
South Asian (SAS) 
 AF: 
AC: 
25734
AN: 
42532
European-Finnish (FIN) 
 AF: 
AC: 
9822
AN: 
17690
Middle Eastern (MID) 
 AF: 
AC: 
602
AN: 
1446
European-Non Finnish (NFE) 
 AF: 
AC: 
89040
AN: 
199198
Other (OTH) 
 AF: 
AC: 
8957
AN: 
19124
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.494 
Heterozygous variant carriers
 0 
 3935 
 7871 
 11806 
 15742 
 19677 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 552 
 1104 
 1656 
 2208 
 2760 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.441  AC: 66948AN: 151658Hom.:  15798  Cov.: 32 AF XY:  0.456  AC XY: 33819AN XY: 74138 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
66948
AN: 
151658
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
33819
AN XY: 
74138
show subpopulations 
African (AFR) 
 AF: 
AC: 
12115
AN: 
41154
American (AMR) 
 AF: 
AC: 
8257
AN: 
15254
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1401
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
3802
AN: 
5158
South Asian (SAS) 
 AF: 
AC: 
2984
AN: 
4820
European-Finnish (FIN) 
 AF: 
AC: 
6248
AN: 
10564
Middle Eastern (MID) 
 AF: 
AC: 
111
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
30542
AN: 
67928
Other (OTH) 
 AF: 
AC: 
928
AN: 
2108
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.503 
Heterozygous variant carriers
 0 
 1812 
 3623 
 5435 
 7246 
 9058 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 628 
 1256 
 1884 
 2512 
 3140 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2255
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.